Literature DB >> 19955366

The role of rhodopsin glycosylation in protein folding, trafficking, and light-sensitive retinal degeneration.

Beatrice M Tam1, Orson L Moritz.   

Abstract

Several mutations in the N terminus of the G-protein-coupled receptor rhodopsin disrupt NXS/T consensus sequences for N-linked glycosylation (located at N2 and N15) and cause sector retinitis pigmentosa in which the inferior retina preferentially degenerates. Here we examined the role of rhodopsin glycosylation in biosynthesis, trafficking, and retinal degeneration (RD) using transgenic Xenopus laevis expressing glycosylation-defective human rhodopsin mutants. Although mutations T4K and T4N caused RD, N2S and T4V did not, demonstrating that glycosylation at N2 was not required for photoreceptor viability. In contrast, similar mutations eliminating glycosylation at N15 (N15S and T17M) caused rod death. Expression of T17M was more toxic than T4K to transgenic photoreceptors, further suggesting that glycosylation at N15 plays a more important physiological role than glycosylation at N2. Together, these results indicate that the structure of the rhodopsin N terminus must be maintained by an appropriate amino acid sequence surrounding N2 and may require a carbohydrate moiety at N15. The mutant rhodopsins were rendered less toxic in their dark inactive states, because RD was abolished or significantly reduced when transgenic tadpoles expressing T4K, T17M, and N2S/N15S were protected from light exposure. Regardless of their effect on rod viability, all of the mutants primarily localized to the outer segment and Golgi and showed little or no endoplasmic reticulum accumulation. Thus, glycosylation was not crucial for rhodopsin biosynthesis or trafficking. Interestingly, expression of similar bovine rhodopsin mutants did not cause rod cell death, possibly attributable to greater stability of bovine rhodopsin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955366      PMCID: PMC6665958          DOI: 10.1523/JNEUROSCI.4259-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease.

Authors:  Benjamin M Scott; Steven K Chen; Nihar Bhattacharyya; Abdiwahab Y Moalim; Sergey V Plotnikov; Elise Heon; Sergio G Peisajovich; Belinda S W Chang
Journal:  Genetics       Date:  2018-12-04       Impact factor: 4.562

2.  Organization of cGMP sensing structures on the rod photoreceptor outer segment plasma membrane.

Authors:  Ina Nemet; Guilian Tian; Yoshikazu Imanishi
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

3.  Valproic Acid for a Treatment of Retinitis Pigmentosa: Reasons for Optimism and Caution.

Authors:  Levi Todd; Christopher Zelinka
Journal:  J Neurosci       Date:  2017-05-24       Impact factor: 6.167

4.  Glycosylation of rhodopsin is necessary for its stability and incorporation into photoreceptor outer segment discs.

Authors:  Anne R Murray; Linda Vuong; Daniel Brobst; Steven J Fliesler; Neal S Peachey; Marina S Gorbatyuk; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  Hum Mol Genet       Date:  2015-01-30       Impact factor: 6.150

5.  Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.

Authors:  Simone Iwabe; Gui-Shuang Ying; Gustavo D Aguirre; William A Beltran
Journal:  Exp Eye Res       Date:  2016-04-13       Impact factor: 3.467

6.  Light Induces Ultrastructural Changes in Rod Outer and Inner Segments, Including Autophagy, in a Transgenic Xenopus laevis P23H Rhodopsin Model of Retinitis Pigmentosa.

Authors:  Tami H Bogéa; Runxia H Wen; Orson L Moritz
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

7.  Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa.

Authors:  Ruanne Y J Vent-Schmidt; Runxia H Wen; Zusheng Zong; Colette N Chiu; Beatrice M Tam; Christopher G May; Orson L Moritz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

8.  Photoactivation-induced instability of rhodopsin mutants T4K and T17M in rod outer segments underlies retinal degeneration in X. laevis transgenic models of retinitis pigmentosa.

Authors:  Beatrice M Tam; Syed M Noorwez; Shalesh Kaushal; Masahiro Kono; Orson L Moritz
Journal:  J Neurosci       Date:  2014-10-01       Impact factor: 6.167

Review 9.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

10.  Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.

Authors:  Artur V Cideciyan; Raghavi Sudharsan; Valérie L Dufour; Michael T Massengill; Simone Iwabe; Malgorzata Swider; Brianna Lisi; Alexander Sumaroka; Luis Felipe Marinho; Tatyana Appelbaum; Brian Rossmiller; William W Hauswirth; Samuel G Jacobson; Alfred S Lewin; Gustavo D Aguirre; William A Beltran
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.